Health Care & Life Sciences » Biotechnology | Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
13,467.30
10,456.80
40,572.10
35,368.40
42,220.10
30,481.90
SG&A Expense
32,912.40
48,383.50
73,937.20
109,518.30
123,393.90
119,576.30
EBIT
21,544.30
39,496.00
35,283.70
77,235.90
84,642.90
94,091.10
Unusual Expense
46,671.40
3,024.40
2,504.00
1,238.30
806.80
360.80
Non Operating Income/Expense
1,961.00
331.50
1,579.10
2,257.30
4,369.70
1,067.70
Pretax Income
66,083.50
36,140.10
31,200.60
73,740.30
88,205.80
94,798
Income Tax
-
-
2,097.80
-
-
2,169.80
Consolidated Net Income
66,083.50
36,140.10
29,102.80
73,740.30
88,205.80
96,967.80
Net Income
66,028.40
36,121.70
29,187.60
73,740.30
88,205.80
96,967.80
Net Income After Extraordinaries
66,028.40
36,121.70
29,187.60
73,740.30
88,205.80
96,967.80
Net Income Available to Common
66,028.40
36,121.70
29,187.60
73,740.30
88,205.80
96,967.80
EPS (Basic)
1.44
0.64
0.44
1.01
1.09
1.05
Basic Shares Outstanding
46,087.80
59,127.30
68,198.10
73,214.80
81,777.50
92,540
EPS (Diluted)
1.43
0.64
0.44
1.01
1.09
1.05
Diluted Shares Outstanding
46,087.80
59,408.30
68,365.30
73,214.80
81,918.00
92,540
EBITDA
19,445.00
37,926.70
33,365.10
74,150.00
81,173.90
89,094.40
Non-Operating Interest Income
171.20
-
-
-
-
-
Minority Interest Expense
55.10
18.40
84.80
-
-
-

About Inovio Pharmaceuticals

View Profile
Address
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462
United States
Employees -
Website http://www.inovio.com
Updated 07/08/2019
Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.